145 related articles for article (PubMed ID: 17430632)
1. Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice.
Wyska E; Szymura-Oleksiak J; Pekala E; Obruśnik A
J Pharm Pharmacol; 2007 Apr; 59(4):495-501. PubMed ID: 17430632
[TBL] [Abstract][Full Text] [Related]
2. Interconversion and tissue distribution of pentoxifylline and lisofylline in mice.
Wyska E; Pekala E; Szymura-Oleksiak J
Chirality; 2006 Aug; 18(8):644-51. PubMed ID: 16721727
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice.
Wyska E; Świerczek A; Pociecha K; Przejczowska-Pomierny K
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):403-12. PubMed ID: 25663650
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits.
Adcock KG; Kyle PB; Deaton JS; Olivier JH; Hogan SM
Pharmacotherapy; 2007 Feb; 27(2):200-6. PubMed ID: 17253910
[TBL] [Abstract][Full Text] [Related]
5. Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in normal dogs.
Rees CA; Boothe DM; Boeckh A; Wilkie S; Esparza T; Green R
Vet Ther; 2003; 4(2):188-96. PubMed ID: 14506595
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic modeling of methylxanthine derivatives in mice challenged with high-dose lipopolysaccharide.
Wyska E
Pharmacology; 2010; 85(5):264-71. PubMed ID: 20389149
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction between verapamil and methylxanthine derivatives in mice.
Wyska E
Drug Metab Lett; 2010 Jan; 4(1):15-24. PubMed ID: 20201780
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous estimation of lisofylline and pentoxifylline in rat plasma by high performance liquid chromatography-photodiode array detector and its application to pharmacokinetics in rat.
Italiya KS; Sharma S; Kothari I; Chitkara D; Mittal A
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():49-56. PubMed ID: 28704725
[TBL] [Abstract][Full Text] [Related]
9. Lisofylline causes rapid and prolonged suppression of serum levels of free fatty acids.
Bursten SL; Federighi D; Wald J; Meengs B; Spickler W; Nudelman E
J Pharmacol Exp Ther; 1998 Jan; 284(1):337-45. PubMed ID: 9435196
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of pentoxifylline in dogs after oral and intravenous administration.
Marsella R; Nicklin CF; Munson JW; Roberts SM
Am J Vet Res; 2000 Jun; 61(6):631-7. PubMed ID: 10850837
[TBL] [Abstract][Full Text] [Related]
11. Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats.
Varanasi KK; Potharaju S; Rajak S; Veeraraghavan S; Mallick P; Vakkalanka SK
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):537-42. PubMed ID: 18985182
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.
De Boever S; Baert K; De Backer P; Croubels S
J Vet Pharmacol Ther; 2005 Dec; 28(6):575-80. PubMed ID: 16343291
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
Liska DA; Akucewich LH; Marsella R; Maxwell LK; Barbara JE; Cole CA
Am J Vet Res; 2006 Sep; 67(9):1621-7. PubMed ID: 16948611
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticulate tablet dosage form of lisofylline-linoleic acid conjugate for type 1 diabetes: in situ single-pass intestinal perfusion (SPIP) studies and pharmacokinetics in rat.
Italiya KS; Singh AK; Chitkara D; Mittal A
AAPS PharmSciTech; 2021 Mar; 22(3):114. PubMed ID: 33763759
[TBL] [Abstract][Full Text] [Related]
15. Validation of a high-performance liquid chromatography method for pharmacokinetic evaluation of pentoxifylline and lisofylline in rat serum and tissues.
Walczak M; Szymura-Oleksiak J; Pekala E
Acta Pol Pharm; 2009; 66(3):215-24. PubMed ID: 19645320
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite following intravenous administration in cattle.
Uney K; Tras B; Corum O; Yildiz R; Maden M
Trop Anim Health Prod; 2019 Feb; 51(2):435-441. PubMed ID: 30219998
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans.
Nicklasson M; Björkman S; Roth B; Jönsson M; Höglund P
Chirality; 2002 Aug; 14(8):643-52. PubMed ID: 12125034
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of pentoxifylline and lisofylline on deformability and aggregation of red blood cells from healthy subjects and patients with chronic venous disease.
Słoczyńska K; Kózka M; Pękala E; Marchewka A; Marona H
Acta Biochim Pol; 2013; 60(1):129-35. PubMed ID: 23520579
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of (-)-epicatechin in rabbits.
Chen YA; Hsu KY
Arch Pharm Res; 2009 Jan; 32(1):149-54. PubMed ID: 19183888
[TBL] [Abstract][Full Text] [Related]
20. Enantioselective biotransformation of pentoxifylline into lisofylline using wine yeast biocatalysis.
Pekala E; Wójcik T
Acta Pol Pharm; 2007; 64(2):109-13. PubMed ID: 17665859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
